Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

The Lancet

dengue fever mosquito

Dosing of GSK’s malaria vaccine due to start in 2018

WHO sanctions pilot programme in sub-Saharan Africa to begin gathering field data

dengue fever mosquito

Malaria vaccine is first to provide ‘sustained protection’

Latest trial shows immunological response lasts for at least a year

dengue fever mosquito

World first as CHMP backs GSK malaria vaccine Mosquirix

The EMA's scientific advisers recommend its useoutside Europe

- PMLiVE

Merck Serono signs agreement to develop antimalarial therapy

Deal means the German firm obtains rights to candidate DDD107498

- PMLiVE

Novartis brings creative malaria campaign to Pinterest

Invites users to create their own mosquito-killing story

Novartis building

Novartis to deliver three million malaria treatments in Zambia

Part of Malaria No More’s Power of One campaign

- PMLiVE

Sanofi ships synthetic malaria jab

French manufacturer says Gates Foundation-funded venture could widen treatment

Novartis building

Novartis: novel antimalarial is ‘game-changing’

Says cipargamin could be first new class of malaria drugs in 20 years

dengue fever mosquito

GSK seeks approval for first malaria vaccine

Submits marketing application to European Medicines Agency

EU flag

Europe extends clinical trial project with African researchers

Partnership has already developed eight improved medical treatments

Novartis building

Scientists finds new drug target for malaria

Novartis and academics identify new class of medicines to treat all stages of infection

- PMLiVE

GSK hoping to file malaria vaccine next year

New phase III data backs submission plans

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links